SCHEMBL28085474

SCHEMBL28085474

COc1cccc(Oc2ccc(OB(O)O)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.61
MTNR1B P49286 11/20 0.54
MTNR1A P48039 7/20 0.54
ENPP2 Q13822 1/20 0.50
PGR P06401 3/20 0.49
LTA4H P09960 1/20 0.48
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
ACACB O00763 1/20 0.46
MEN1 O00255 1/20 0.46
MITF O75030 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
GFER P55789 1/20 0.46
KMT2A Q03164 1/20 0.46
NLRP1 Q9C000 1/20 0.46
NOD2 Q9HC29 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1676924 0.87 ENPP2 (0.59) SMN1; SMN2ENPP2ALDH1A1
SCHEMBL28085472 0.85 LTA4H (0.58) ENPP2LTA4HMEN1ALDH1A1MAPT
SCHEMBL10709191 0.84 SMN1; SMN2 (0.80) SMN1; SMN2MTNR1BMTNR1APGRLTA4H
SCHEMBL11049862 0.82 SMN1; SMN2 (0.77) SMN1; SMN2MTNR1BMTNR1APGRLTA4H
SCHEMBL257918 0.82 ENPP2 (0.65) SMN1; SMN2MTNR1BMTNR1AENPP2PGR
SCHEMBL1943711 0.81 LTA4H (0.50) SMN1; SMN2LTA4HKDM4EMEN1MITF
SCHEMBL4608736 0.80 SMN1; SMN2 (0.73) SMN1; SMN2MTNR1BMTNR1APGRLTA4H
SCHEMBL29929943 0.80 SMN1; SMN2 (0.72) SMN1; SMN2MTNR1BMTNR1AENPP2PGR
SCHEMBL30053231 0.80 SMN1; SMN2 (0.72) SMN1; SMN2MTNR1BMTNR1AENPP2PGR
SCHEMBL1061713 0.80 SMN1; SMN2 (0.72) SMN1; SMN2MTNR1BMTNR1AENPP2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104844609-B The irreversible bruton's tyrosine kinase inhibitor of dibit point 杭州和正医药有限公司 2016-07-13 CN disclosed